Arterial Resection During Pancreatectomy for Pancreatic Cancer

医学 胰腺切除术 围手术期 禁忌症 优势比 胰腺癌 回顾性队列研究 置信区间 科克伦图书馆 外科 危险系数 内科学 癌症 普通外科 切除术 替代医学 病理
作者
Nathan M. Mollberg,Nuh N. Rahbari,Moritz Koch,Werner Hartwig,Yumiko Hoeger,Markus W. Büchler,Jürgen Weitz
出处
期刊:Annals of Surgery [Lippincott Williams & Wilkins]
卷期号:254 (6): 882-893 被引量:433
标识
DOI:10.1097/sla.0b013e31823ac299
摘要

The majority of pancreatic cancers are diagnosed at an advanced stage. As surgical resection remains the only hope for cure, more aggressive surgical approaches have been advocated to increase resection rates. Institutions have begun to release data on their experience with pancreatectomy and simultaneous arterial resection (AR), which has traditionally been considered a general contraindication to resection. The aim of the present meta-analysis was to evaluate the perioperative and long-term outcomes of patients with AR during pancreatectomy for pancreatic cancer.The Medline, Embase, and Cochrane Library and J-East databases were systematically searched to identify studies reporting outcome of patients who underwent pancreatectomy with AR for pancreatic cancer. Studies that reported perioperative and/or long-term results after pancreatectomy with AR were eligible for inclusion. Meta-analyses included comparative studies providing data on patients with and without AR and were performed using a random effects model.The literature search identified 26 studies including 366 and 2243 patients who underwent pancreatectomy with and without AR. All studies were retrospective cohort studies and the methodological quality was moderate to low. Meta-analyses revealed AR to be associated with a significantly increased risk for perioperative mortality [Odds ratio (OR) = 5.04; 95% confidence interval (CI), 2.69-9.45; P < 0.0001; I² = 24%], poor survival at 1 year (OR = 0.49; 95% CI, 0.31-0.78; P = 0.002; I² = 35%) and 3 years (OR = 0.39; 95% CI, 0.17-0.86; P = 0.02; I² = 49%) compared with patients without AR. The increased perioperative mortality (OR = 8.87; 95% CI, 3.40-23.13; P < 0.0001; I² = 5%) and lower survival rate at 1 year (OR = 0.50; 95% CI, 0.31-0.82; P = 0.006; I² = 40%) was confirmed in the comparison to patients undergoing venous resection. Despite substantial perioperative mortality, pancreatectomy with AR was associated with more favorable survival compared with patients who did not undergo resection for locally advanced disease.AR in patients undergoing pancreatectomy for pancreatic cancer is associated with a poor short and long-term outcome. Pancreatectomy with AR may, however, be justified in highly selected patients owing to the potential survival benefit compared with patients without resection. These patients should be treated within the bounds of clinical trials to assess outcomes after AR in the era of modern pancreatic surgery and multimodal therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ouyang完成签到,获得积分10
刚刚
hdy331完成签到,获得积分0
刚刚
杨召发布了新的文献求助10
1秒前
所所的应助被微血管采纳,获得10
2秒前
3秒前
CipherSage的应助被霜影采纳,获得10
3秒前
4秒前
4秒前
4秒前
4秒前
FashionBoy的应助被qianzhihe采纳,获得10
4秒前
SLL发布了新的文献求助10
4秒前
5秒前
5秒前
简隋英完成签到,获得积分10
5秒前
5秒前
Lycoris林曦发布了新的文献求助10
5秒前
Akim的应助被ZD采纳,获得10
5秒前
pinecone发布了新的文献求助30
6秒前
6秒前
6秒前
xinyuanjia发布了新的文献求助10
6秒前
dbwdqqr完成签到,获得积分20
7秒前
7秒前
liu45kf发布了新的文献求助10
7秒前
tian发布了新的文献求助10
8秒前
晓强完成签到 ,获得积分10
8秒前
科研通AI6.2的应助被黄燕采纳,获得10
8秒前
小二郎的应助被第一作者采纳,获得10
8秒前
杨召完成签到,获得积分10
9秒前
bkagyin的应助被落寞语兰采纳,获得10
9秒前
西里贝里发布了新的文献求助10
9秒前
许寻笙发布了新的文献求助30
9秒前
风筝与亭完成签到,获得积分10
9秒前
Hello的应助被雯雯采纳,获得10
9秒前
小二_来篇一作完成签到,获得积分10
10秒前
斯文可仁发布了新的文献求助10
10秒前
zuo发布了新的文献求助10
10秒前
11秒前
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187748
求助须知:如何正确求助?哪些是违规求助? 9575825
关于积分的说明 21843288
捐赠科研通 7785628
什么是DOI,文献DOI怎么找? 3435097
关于科研通互助平台的介绍 2559495
邀请新用户注册赠送积分活动 2482000